Proton magnetic resonance spectroscopy as a monitoring tool for electroconvulsive therapy effects on the brain

Current Psychiatry Reviews

Volumn 2, Issue 1, 2006, Pages 39-49

  Sartorius, Alexander ^a   Henn, Fritz A ^a   Ende, Gabriele ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Animal model; ECT; Electroconvulsive therapy; Major depression; MDD; Proton magnetic resonance spectroscopy (1H MRS)

Indexed keywords

4 AMINOBUTYRIC ACID; 5 [[2 [1 [3,5 BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY] 3 (4 FLUOROPHENYL) 4 MORPHOLINYL]METHYL] N,N DIMETHYL 1H 1,2,3 TRIAZOLE 4 METHANAMINE; ACETYLCHOLINE; CHOLINE; CLOMIPRAMINE; CREATINE; CREATINE PHOSPHATE; FATTY ACID; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; LIPID; LITHIUM SALT; LORAZEPAM; N ACETYLASPARTIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRIACYLGLYCEROL; VALPROIC ACID;

4 AMINOBUTYRIC ACID RELEASE; BIPOLAR DISORDER; BRAIN METABOLISM; BRAIN REGION; COGNITIVE DEFECT; DEPRESSION; DEPRESSIVE PSYCHOSIS; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; HUMAN; LEARNED HELPLESSNESS; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NON INVASIVE PROCEDURE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIVITY ANALYSIS; SYNAPTOGENESIS; TREATMENT RESPONSE;

EID: 33745833988     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340006775101445     Document Type: Review

References (66)

1. Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. 2nd ed. Washington, DC: Am Psychiatr Assoc, 2001.
2. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244-253.
3. Fink M. How does convulsive therapy work? Neuropsychopharmacology 1990; 3: 73-82.
4. Henn FA, Vollmayr B, Sartorius A. Mechanisms of depression: the role of neurogenesis. Drug Discovery Today: Disease Mechanisms 2004; 1: 407-411.
5. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46: 1181-1191.
6. Jacobsen JP, Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004; 1024: 183-192.
7. Altar CA, Laeng P, Jurata LW, et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 2004; 24: 2667-2677.
8. Zetterstrom TS, Pei Q, Grahame-Smith DG. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 1998; 57: 106-110.
9. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre BW. Mossy fiber sprouting induced by repeated electroconvulsive shock eizures. Brain Res 1999; 844: 28-33.
10. Madhav TR, Pei Q, Grahame-Smith DG, Zetterstrom TS. Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus. Neuroscience 2000; 97: 677-683.
11. Dremencov E, Gur E, Lerer B, Newman ME. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 729-739.
12. Zachrisson OC, Balldin J, Ekman R, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res 2000; 96: 157-165.
13. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure? Am J Psychiatry 1994; 151: 957-970.
14. Moore GJ, Galloway MP. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol Bull 2002; 36: 5-23.
15. Woods BT, Chin TM. In vivo 1H spectroscopy of the human brain following electroconvulsive therapy. Ann Neurol 1990; 28: 745-749.
16. Felber SR, Pycha R, Hummer M, Aichner FT, Fleischhacker WW. Localized proton and phosphorus magnetic resonance spectroscopy following electroconvulsive therapy. Biol Psychiatry 1993; 33: 651-654.
17. Pfleiderer B, Michael N, Erfurth A, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003; 122: 185-192.
18. Michael N, Erfurth A, Ohrmann P, et al. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 2003; 33: 1277-1284.
19. Michael N, Erfurth A, Ohrmann P, et al. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 2003; 28: 720-725.
20. Sanacora G, Mason GF, Rothman DL, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160: 577-579.
21. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000; 57: 937-943.
22. Obergriesser T, Ende G, Braus DF, Henn FA. Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. J Clin Psychiatry 2003; 64: 775-780.
23. Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myoinositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 2005; 7: 1-10.
24. Harwood AJ. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry 2005; 10: 117-126.
25. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 2004; 27: 489-495.
26. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993; 90: 5662-5666.
27. Auer DP, Putz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000; 47: 305-313.
28. Friedman SD, Dager SR, Parow A, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 2004; 56: 340-348.
29. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002; 159: 663-665.
30. Bhagwagar Z, Wylezinska M, Taylor M, et al. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004; 161: 368-370.
31. Keltner JR, Wald LL, Frederick BD, Renshaw PF. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn Reson Med 1997; 37: 366-371.
32. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34: 275-281.
33. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8: 721-37, 715.
34. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45: 37-45.
35. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002; 125(Pt 10): 2332-2341.
36. Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol 2002; 59: 955-962.
37. Blasi G, Bertolino A, Brudaglio F, et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004; 131: 95-105.
38. Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-481.
39. Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003; 160: 873-882.
40. Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 2001; 8: 1-7.
41. Sartorius A, Vollmayr B, Neumann-Haefelin C, et al. Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 2003; 14: 2199-2201.
42. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 2001; 98: 12796-12801.
43. van der Hart MG, Czeh B, de Biurrun G, et al. Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry 2002; 7: 933-941.
44. Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 2004; 14 Suppl 5: S481-S490.
45. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516-1518.
46. Ballmaier M, Toga AW, Blanton RE, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161: 99-108.
47. Boulanger Y, Labelle M, Khiat A. Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Res Brain Res Rev 2000; 33: 380-389.
48. Danielsen E, Ross B. The clinical significance of metabolites. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker Inc., 1999: 23-43.
49. Bertolino A, Frye M, Callicott JH, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003; 53: 906-913.
50. Kumar A, Thomas A, Lavretsky H, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 2002; 159: 630-636.
51. Moore CM, Breeze JL, Gruber SA, et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000; 2(3 Pt 2): 207-216.
52. Sartorius A, Neumann-Haefelin C, Vollmayr B, Hoehn M, Henn FA. Choline rise in the rat hippocampus induced by electroconvulsive shock treatment. Biol Psychiatry 2003; 53: 620-623.
53. Ke Y, Cohen BM, Lowen S, et al. Biexponential transverse relaxation (T(2)) of the proton MRS creatine resonance in human brain. Magn Reson Med 2002; 47: 232-238.
54. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10: 191-247.
55. Pettegrew JW, Levine J, Gershon S, et al. 31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results. Bipolar Disord 2002; 4: 61-66.
56. Kato T. The other, forgotten genome: mitochondrial DNA and mental disorders. Mol Psychiatry 2001; 6: 625-633.
57. Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998; 10: 133-147.
58. Videbech P, Ravnkilde B, Pedersen AR, et al. The Danish PET/depression project: PET findings in patients with major depression. Psychol Med 2001; 31: 1147-1158.
59. Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005; 14: 241-253.
60. Woods BT, Chiu TM. Induced and spontaneous seizures in man produce increases in regional brain lipid detected by in vivo proton magnetic resonance spectroscopy. Adv Exp Med Biol 1992; 318: 267-274.
61. Soares JC, Krishnan KR, Keshavan MS. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996; 4: 14-30.
62. Mander AJ, Whitfield A, Kean DM, et al. Cerebral and brain stem changes after ECT revealed by nuclear magnetic resonance imaging. Br J Psychiatry 1987; 151: 69-71.
63. Scott AI, Douglas RH, Whitfield A, Kendell RE. Time course of cerebra; magnetic resonance changes after electroconvulsive therapy. Br J Psychiatry 1990; 156: 551-553.
64. Diehl DJ, Keshavan MS, Kanal E, et al. Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study. Psychiatry Res 1994; 54: 177-184.
65. Besson JA, Reid IC. Relationship between observed NMR changes and brain water content following electroconvulsive stimulation in the rat. J Affect Disord 1991; 22: 159-164.
66. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001; 98: 12796-12801.